Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
Saved in:
| Title: | Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE. |
|---|---|
| Authors: | Perez, Edith A.1 (AUTHOR) perez.edith@mayo.edu, Barrios, Carlos2 (AUTHOR), Eiermann, Wolfgang3 (AUTHOR), Toi, Masakazu4 (AUTHOR), Im, Young‐Hyuck5 (AUTHOR), Conte, Pierfranco6,7 (AUTHOR), Martin, Miguel8 (AUTHOR), Pienkowski, Tadeusz9 (AUTHOR), Pivot, Xavier B.10 (AUTHOR), Burris, Howard A.11 (AUTHOR), Petersen, Jennifer A.12 (AUTHOR), De Haas, Sanne13 (AUTHOR), Hoersch, Silke13 (AUTHOR), Patre, Monika13 (AUTHOR), Ellis, Paul Anthony14 (AUTHOR), Im, Young-Hyuck15 (AUTHOR), Burris, Howard A 3rd16 (AUTHOR) |
| Source: | Cancer (0008543X). Nov2019, Vol. 125 Issue 22, p3974-3984. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
